Drug profile · INN
methoxsalen
UVADEX
methoxsalen (UVADEX) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
FDA: approved TGA: approved
US status approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — methoxsalen
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
methoxsalen (UVADEX) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN methoxsalen
Brand UVADEX
Mechanism DNA inhibitor
Target DNA
Route TOPICAL
Formulation LOTION
Mechanism of action
DNA inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is methoxsalen?
methoxsalen (UVADEX) is a dna inhibitor. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for methoxsalen?
UVADEX is a marketed brand name for methoxsalen. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methoxsalen?
methoxsalen has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.